IBD’s Chronic Nature May Be Due to Long-Lived Immune Cell
New findings may provide new therapeutic target and help explain why IBD and other autoimmune diseases are often chronic and life-long
Related Articles
The State of Omics 2024, Wed, Apr 17th, 2024 @ 11:00 AM Mary Ann Liebert, Inc. publishers
The past two years have seen exciting advances in the world of genomics, as several companies threaten to disrupt the next-gen sequencing (NGS) establishment. Meanwhile,…
Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses
Researchers say there is little chance of a virus mutating to avoid this vaccination strategy, which blocks viral ability to suppress host RNAi responses.
Best of NGS: The Instrument Companies to Watch
Long-time leader Illumina and several challengers have been stepping up launches of new next-generation sequencing instruments.
Merck Launches All-in-One Genetic Stability Assay for Biosafety Testing
Currently, FDA guidance requires biotech companies to use multiple assays to address genetic stability requirements. This traditional package of assays is costly, time-consuming, and often…
Muscle Cell Atlas to Strengthen Research into Age-Related Deterioration
Insights into skeletal muscle ageing could help researchers explore ways to combat inflammation, boost muscle regeneration and preserve nerve connectivity
SPARDA: A Programmable Nucleic Acid Targeting Technology Like CRISPR
SPARDA and other systems that encode diverse effectors have the potential to offer a novel programmable tool for the field of biotechnology.
New Insights Could Boost Immunotherapy for Rare Eye Cancer
New insights may explain why uveal melanoma is resistant to conventional immunotherapies.
The State of Omics 2024, Wed, Apr 17th, 2024 @ 11:00 AM Mary Ann Liebert, Inc. publishers
The past two years have seen exciting advances in the world of genomics, as several companies threaten to disrupt the next-gen sequencing (NGS) establishment. Meanwhile,…
Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap
On this week’s Touching Base podcast, the GEN editors discuss the launch of Nvelop Therapeutics, a new start-up leveraging approaches developed by gene editing pioneers David…
Online Event
Quantitative real-time PCR (qPCR) and digital PCR (dPCR) are powerful molecular biology techniques for quantifying and analyzing DNA or RNA, but they differ in their…